
Johnson Fistel, PLLP is investigating whether Select Medical Holdings' board breached fiduciary duties in the proposed $16.50 per share sale to a consortium led by company insiders and Welsh, Carson, Anderson & Stowe. The deal, expected to close mid-2026, would take Select Medical private and delist its shares from the NYSE. The investigation questions if the board maximized shareholder value and if minority shareholders are fairly compensated. Shareholders dissatisfied with the offer are encouraged to join the probe.